RankAlpha logo
Back to Rankings

SERA

Sera PrognosticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
SERA vs peer average
36/100
SERA vs. peer average (F vs. D)
Grade spread
B 1 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CSBR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $79.5M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCSBRChampions Oncology
SERA
Sera Prognostics
CSBR
Champions Oncology
Grade
F
D
Momentum
28
31
Value
41
62
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CSBR

SERA / CSBR
Grade Position
Below peers
SERA vs. peer average (F vs. D)
36/100
Momentum
28
CSBR
Value
41
CSBR
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SERA
1
CSBR
Champions Oncology Inc Common
D
40/100
-1
2
BTMD
biote Corp Class A Common
D
40/100
-1
3
GANX
Gain Therapeutics Inc Common
B
80/100
-3
4
EXOZ
eXoZymes Inc Common
N/A
-
-
5
ACET
Adicet Bio Inc Common
F
20/100
Even
CSBR is the first peer returned for this comparison set.